Chen Yung-Chan, Kao Li-Ting, Lin Herng-Ching, Lee Hsin-Chien, Huang Chung-Chien, Chung Shiu-Dong
Department of Psychiatry, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
Graduate Institute of Life Science, National Defense Medical Center, Taipei, Taiwan.
BMC Urol. 2016 Nov 16;16(1):67. doi: 10.1186/s12894-016-0187-x.
Anxiety disorders (ADs) are common with a high rate of medical comorbidities. Although the association between ADs and the overall cancer risk remains controversial, patients with ADs were found to be more likely to develop specific cancer types. Herein, we estimated the risk of developing urological cancers among patients with ADs in a 5-year follow-up period using a population-based database.
Two study cohorts were identified from the Taiwan Longitudinal Health Insurance Database 2005: patients with ADs, and comparison subjects selected by one-to-one matching for sex, age, and the year of recruitment. Follow-up was undertaken to determine whether sampled patients and comparison subjects had developed urological cancers in the subsequent 5 years.
We found that urological cancers occurred among 0.54% of patients with ADs and 0.13% of comparison subjects. After adjusting for sociodemographic characteristics, medical comorbidities, and alcohol and tobacco use disorder, the stratified Cox proportional hazard regression suggested that patients with ADs were more likely to develop urological cancers relative to comparison subjects (adjusted hazard ratio, 3.67; 95% confidence interval, 2.85 ~ 4.72). The adjusted HR for males with ADs was 3.82 (95% CI: 2.79 ~ 5.23) in comparison to males without ADs. In addition, the adjusted HR for females with ADs was 3.47 (95% CI: 2.26 ~ 5.31) than those females without ADs.
We concluded that during the 5-year follow-up period, there was a significantly increased risk of urological cancers among patients with ADs.
焦虑症(ADs)很常见,且合并其他疾病的发生率很高。尽管焦虑症与总体癌症风险之间的关联仍存在争议,但发现患有焦虑症的患者更有可能患特定类型的癌症。在此,我们使用基于人群的数据库估计了焦虑症患者在5年随访期内患泌尿系统癌症的风险。
从2005年台湾纵向健康保险数据库中确定了两个研究队列:焦虑症患者,以及通过性别、年龄和招募年份一对一匹配选择的对照对象。进行随访以确定抽样患者和对照对象在随后5年中是否患了泌尿系统癌症。
我们发现,0.54%的焦虑症患者和0.13%的对照对象患了泌尿系统癌症。在调整了社会人口统计学特征、合并疾病以及酒精和烟草使用障碍后,分层Cox比例风险回归表明,与对照对象相比,焦虑症患者患泌尿系统癌症的可能性更大(调整后的风险比为3.67;95%置信区间为2.85至4.72)。与无焦虑症的男性相比,患有焦虑症的男性调整后的风险比为3.82(95%置信区间:2.79至5.23)。此外,患有焦虑症的女性调整后的风险比为3.47(95%置信区间:2.26至5.31),高于无焦虑症的女性。
我们得出结论,在5年随访期内,焦虑症患者患泌尿系统癌症的风险显著增加。